Endovenous Laser Ablation (EVLA) Device Market to Grow at a CAGR of 7.3% Through 2032

According to a newly published market research report by 24LifeSciences, global Endovenous Laser Ablation (EVLA) Device market was valued at USD 316 million in 2024 and is projected to reach USD 507 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20252031.

Endovenous Laser Ablation (EVLA) devices are specialized medical instruments designed for the minimally invasive treatment of venous disorders. These advanced systems operate by precisely transmitting laser energy through a fine optical fiber inserted directly into the diseased vein. The thermal energy delivered causes controlled damage to the venous wall, leading to fibrosis and eventual closure of the vessel. This mechanism effectively addresses abnormal blood flow patterns associated with conditions like chronic venous insufficiency and lower limb varicose veins. The procedure's key advantages include minimal patient discomfort, rapid recovery times, significantly reduced complication rates compared to traditional surgery, and consistently high clinical efficacy rates that often exceed 95% success in long-term studies.

Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4784/endovenous-laser-ablation-evla-device-market

Growing Preference for Minimally Invasive Treatments Drives Market Expansion
The increasing global patient preference for minimally invasive procedures over traditional venous surgery represents a fundamental growth driver for EVLA device adoption. Patients increasingly choose EVLA procedures due to their reduced scarring, shorter recovery periods, and substantially lower complication rates when compared to conventional vein stripping surgery. This shift in patient preference is reinforced by clinical outcomes that demonstrate superior results and faster return to normal activities.